Recap: Precigen Q4 Earnings
Portfolio Pulse from Benzinga Insights
Precigen (NASDAQ:PGEN) reported Q4 earnings with an EPS of $-0.13, missing estimates by -62.0% against an expected $-0.08. Revenue decreased by $535 thousand compared to the same period last year. The company's past earnings performance shows a pattern of missing EPS estimates, which previously led to a 13.0% drop in share price the following day.
March 19, 2024 | 8:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Precigen reported a significant miss in Q4 earnings with an EPS of $-0.13, underperforming against estimates by -62.0%, and a year-over-year revenue decrease.
Given Precigen's history of missing EPS estimates and the subsequent negative impact on its share price, the Q4 earnings miss and revenue decrease are likely to lead to a short-term negative impact on PGEN's stock price. The pattern of underperformance, especially with a significant miss in the latest quarter, suggests investor confidence could be affected, potentially leading to a decrease in share price similar to the 13.0% drop observed in the past.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100